My Worst Investment Decision in 2019

It was best to have bailed out on the bad breaking news as the CannTrust Holdings (TSX:TRST)(NYSE:CTST) scandal unfolded, but was it so obvious?

Disbelief, outright denial, and a fear of booking losses too early can be costly mental biases as far as investment decision making is concerned, and resultant capital losses may prove more permanent than we desire.

These mental states may have significantly influenced a hold decision on Canadian cannabis firm CannTrust Holdings (TSX:TRST)(NYSE:CTST) when everyone else was bailing out of the scandal hit stock. The share price plunged 22% on July 8, 2019, as investors freaked out after the breaking news that the company had grown product in previously unlicensed rooms for six months.

Instead of rushing to the exits like everyone else, I’d recommended a hold on the stock based on the data points that the rooms were subsequently licensed by Health Canada and that the sold product was processed in high-standard licensed facilities, so there was minimal risk to product quality, and the company could potentially get away with fines and penalties.

After all, management had promised that they were already taking remedial action, so the damage could be minimal.

I was very wrong.

Worse news piled onto the stock, as it was later alleged that even the CEO, the most key senior executive, was also involved in the scandal and had directed subordinates to “proceed as planned” in a direct disregard of laws and regulations. Sales were halted, licences revoked, and now the company is battling to meet filling deadlines to remain listed on equities exchange markets.

In hindsight, it was better to have fled when the stock still traded around $4.73 on July 9 last year than to hold out till shares hit a low of $0.99, or 79% lower, by December. The losses could have been minimized.

What else could have influenced the hold decision?

As humans, we have mental and emotional biases, and our investment decisions aren’t always as scientific and well reasoned out as we portray them to be to our peers.

There’s this fear of losing money, and in this case, there was a sudden 22% one-day loss to be booked after the breaking news, yet there was some hope that the situation could be managed better.

Behavioural finance has identified and termed this fear loss aversion. As investors we aren’t necessarily as concerned about the risk on an investment as the traditional economists had theorized, but we tend to fear losses more than we love capital gains.

Due to loss aversion, the average investor will hold on to losing positions for much longer than necessary in the hope for a rebound (to avoid booking losses), and we quickly book small profits way too soon to avoid losing them.

The result is a significant underperformance in the portfolio that could make a passive index investor look like a genius (and then prove Warren Buffett correct in his wager against active investment). Ironically, though, doing nothing in this case cost more money than just selling on the news and asking questions later.

Foolish bottom line

At times it saves to run on the very first signs of trouble, but rushed decisions can also be disastrous in most circumstances. Investors who quickly took losses on Aphria during the LatAm acquisitions scandal may have avoided them just by holding through the turmoil.

That said, the CannTrust scandal is something else, and it has regulatory technicalities like licences revocations and potential delistings from exchanges that could sink the ship faster than investor lawsuits, potential fines, and penalties for wrongdoing.

Bailing out on the bad breaking news was the best call to have been made and one could have bought back into the ticker as a speculative contrarian bet, but it wasn’t as obvious back then.

The big question now is whether CannTrust Holdings stock price can recover in 2020. Maybe we should discuss this interesting part next, and take care to speculate with only a small proportion of your capital this year.

Happy New Year, Fools.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings and CannTrust Holdings Inc.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Here’s Why I Wouldn’t Touch Canopy Growth Stock With a 10-Foot Pole

Down almost 99% from all-time highs, Canopy Growth is a beaten-down cannabis stock that remains a high-risk investment in 2026.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »